151 related articles for article (PubMed ID: 16651880)
1. Bivalirudin for anticoagulation in mechanical aortic valve replacement and heparin-induced thrombocytopenia.
Klein M; Tomer A; Swartz A; Koyffman L; Weksler N
Blood Coagul Fibrinolysis; 2006 Jun; 17(4):331-3. PubMed ID: 16651880
[TBL] [Abstract][Full Text] [Related]
2. Transfemoral Transcatheter Aortic Valve Replacement in a Patient With Heparin-Induced Thrombocytopenia: Intraoperative Anticoagulation Management With Bivalirudin (Angiomax).
Scott B; Tam CW; Moon RS
J Cardiothorac Vasc Anesth; 2015 Dec; 29(6):1603-5. PubMed ID: 25604599
[No Abstract] [Full Text] [Related]
3. Bioline heparin-coated ECMO with bivalirudin anticoagulation in a patient with acute heparin-induced thrombocytopenia: the immune reaction appeared to continue unabated.
Pappalardo F; Maj G; Scandroglio A; Sampietro F; Zangrillo A; Koster A
Perfusion; 2009 Mar; 24(2):135-7. PubMed ID: 19654158
[TBL] [Abstract][Full Text] [Related]
4. Bivalirudin use in carotid endarterectomy in a patient with heparin-induced thrombocytopenia.
Finks SW
Ann Pharmacother; 2006 Feb; 40(2):340-3. PubMed ID: 16449539
[TBL] [Abstract][Full Text] [Related]
5. Safety, efficacy, and dosing requirements of bivalirudin in patients with heparin-induced thrombocytopenia.
Kiser TH; Burch JC; Klem PM; Hassell KL
Pharmacotherapy; 2008 Sep; 28(9):1115-24. PubMed ID: 18752382
[TBL] [Abstract][Full Text] [Related]
6. Anticoagulant monitoring techniques in a heparin-induced thrombocytopenia patient undergoing cardiopulmonary bypass using bivalirudin anticoagulant.
Baker T; Chan R; Hill F
J Extra Corpor Technol; 2004 Dec; 36(4):371-4. PubMed ID: 15679282
[TBL] [Abstract][Full Text] [Related]
7. Argatroban and bivalirudin compared to unfractionated heparin in preventing thrombus formation on mechanical heart valves. Results of an in-vitro study.
Maegdefessel L; Linde T; Michel T; Hamilton K; Steinseifer U; Friedrich I; Schubert S; Hauroeder B; Raaz U; Buerke M; Werdan K; Schlitt A
Thromb Haemost; 2009 Jun; 101(6):1163-9. PubMed ID: 19492162
[TBL] [Abstract][Full Text] [Related]
8. Bivalirudin anticoagulation for cardiopulmonary bypass in a patient with heparin-induced thrombocytopenia.
Wasowicz M; Vegas A; Borger MA; Harwood S
Can J Anaesth; 2005 Dec; 52(10):1093-8. PubMed ID: 16326682
[TBL] [Abstract][Full Text] [Related]
9. Bivalirudin dosing adjustments for reduced renal function with or without hemodialysis in the management of heparin-induced thrombocytopenia.
Tsu LV; Dager WE
Ann Pharmacother; 2011 Oct; 45(10):1185-92. PubMed ID: 21881032
[TBL] [Abstract][Full Text] [Related]
10. Heparin-induced thrombocytopenia and cardiac surgery.
Levy JH; Winkler AM
Curr Opin Anaesthesiol; 2010 Feb; 23(1):74-9. PubMed ID: 19996742
[TBL] [Abstract][Full Text] [Related]
11. Management of refractory bleeding post-cardiopulmonary bypass in an acute heparin-induced thrombocytopenia type II renal failure patient who underwent urgent cardiac surgery with bivalirudin (Angiox
Hassen K; Maccaroni MR; Sabry H; Mukherjee S; Serumadar S; Birdi I
Perfusion; 2018 Apr; 33(3):235-240. PubMed ID: 28789610
[TBL] [Abstract][Full Text] [Related]
12. A Patient With Remote Heparin-Induced Thrombocytopenia and Antiphospholipid Syndrome Requiring Cardiopulmonary Bypass: Do Current Guidelines Apply?
Ibrahim W; Nakia H; Stephen M; Bruce S; Bryan W; William P
Semin Cardiothorac Vasc Anesth; 2019 Jun; 23(2):256-260. PubMed ID: 29871549
[TBL] [Abstract][Full Text] [Related]
13. Bivalirudin anticoagulation for left ventricular assist device implantation on an extracorporeal life support system in patients with heparin-induced thrombocytopenia antibodies.
Ljajikj E; Zittermann A; Morshuis M; Börgermann J; Ruiz-Cano M; Schoenbrodt M; Gummert J; Koster A
Interact Cardiovasc Thorac Surg; 2017 Dec; 25(6):898-904. PubMed ID: 29049666
[TBL] [Abstract][Full Text] [Related]
14. The use of bivalirudin for cardiopulmonary bypass anticoagulation in pediatric heparin-induced thrombocytopenia patients.
Gates R; Yost P; Parker B
Artif Organs; 2010 Aug; 34(8):667-9. PubMed ID: 20528853
[TBL] [Abstract][Full Text] [Related]
15. Correlation of bivalirudin dose with creatinine clearance during treatment of heparin-induced thrombocytopenia.
Runyan CL; Cabral KP; Riker RR; Redding D; May T; Seder DB; Savic M; Hedlund J; Abramson S; Fraser GL
Pharmacotherapy; 2011 Sep; 31(9):850-6. PubMed ID: 21923585
[TBL] [Abstract][Full Text] [Related]
16. Use of systemic bivalirudin with catheter-directed thrombolysis in a patient with heparin-induced thrombocytopenia: A case report.
Badreldin HA; Rimsans J; Connors JM; Wiviott SD
Catheter Cardiovasc Interv; 2018 Feb; 91(3):E17-E20. PubMed ID: 29068112
[TBL] [Abstract][Full Text] [Related]
17. Favorable outcome with bivalirudin anticoagulation during cardiopulmonary bypass.
Davis Z; Anderson R; Short D; Garber D; Valgiusti A
Ann Thorac Surg; 2003 Jan; 75(1):264-5. PubMed ID: 12537226
[TBL] [Abstract][Full Text] [Related]
18. Successful use and dosing of bivalirudin after temporary total artificial heart implantation: a case series.
Crouch MA; Kasirajan V; Cahoon W; Katlaps GJ; Gunnerson KJ
Pharmacotherapy; 2008 Nov; 28(11):1413-20. PubMed ID: 18957002
[TBL] [Abstract][Full Text] [Related]
19. Bivalirudin for prevention of prosthetic valve thrombosis in heparin allergy.
Palacios-Rubio J; Cano L; Vilacosta I; Vivas D
J Card Surg; 2013 Sep; 28(5):520-1. PubMed ID: 23909407
[TBL] [Abstract][Full Text] [Related]
20. Bivalirudin and transcatheter aortic valve replacement: a cautionary tale.
Sangani NK; Greason KL; Torres NE; Suri RM; Mathew V
Ann Thorac Surg; 2014 Dec; 98(6):2214-5. PubMed ID: 25468094
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
